MetLife Investment Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $566K | Hold |
|
|||||
|
2025
Q2 | $374K | Hold |
|
|||||
|
2025
Q1 | $215K | Sell |
|
|||||
|
2024
Q4 | $302K | Buy |
|
|||||
|
2024
Q3 | $234K | Hold |
|
|||||
|
2024
Q2 | $255K | Buy |
|
|||||
|
2024
Q1 | $396K | Buy |
|
|||||
|
2023
Q4 | $323K | Hold |
|
|||||
|
2023
Q3 | $112K | Hold |
|
|||||
|
2023
Q2 | $122K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $102K | Hold |
|
|||||
|
2022
Q2 | $101K | Hold |
|
|||||
|
2022
Q1 | $156K | Buy |
|
|||||
|
2021
Q4 | $101K | Buy |
|